This inventor holds 1 USPTO granted patent. Top assignees: Children's National Medical Center, University System of Maryland. Active years: 2026.
Company Filing History:


Years Active: 2026
Title: Metecan Erdi: Innovator in Wound Treatment Technology
Introduction
Metecan Erdi is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of wound treatment through his innovative patent. His work focuses on developing advanced materials that enhance healing processes.
Latest Patents
Metecan Erdi holds a patent for a "Sprayable tissue adhesive with biodegradation for wound treatment." This invention involves compositions and methods utilizing viscoelastic poly(lactide-co-caprolactone) (PLCL) mixtures. These mixtures are designed for use in wound healing, providing an improved anti-fibrotic yet tissue-adhesive polymer sealant. The PLCL mixtures can be applied to various wounds resulting from both surgical and non-surgical tissue damage.
Career Highlights
Throughout his career, Metecan Erdi has worked with reputable institutions such as Children's National Medical Center and the University System of Maryland. His experience in these organizations has allowed him to develop and refine his innovative ideas in the medical field.
Collaborations
Metecan has collaborated with talented individuals, including Omar Bilal Ayyub and Michele Saruwatari. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Metecan Erdi's contributions to wound treatment technology through his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to impact the field positively.